U.S. Markets open in 4 hrs 44 mins
  • S&P Futures

    4,401.25
    +6.75 (+0.15%)
     
  • Dow Futures

    34,941.00
    -12.00 (-0.03%)
     
  • Nasdaq Futures

    14,988.75
    +41.00 (+0.27%)
     
  • Russell 2000 Futures

    2,201.20
    +14.50 (+0.66%)
     
  • Crude Oil

    72.09
    +0.44 (+0.61%)
     
  • Gold

    1,798.90
    -0.90 (-0.05%)
     
  • Silver

    24.78
    +0.13 (+0.53%)
     
  • EUR/USD

    1.1819
    -0.0007 (-0.0591%)
     
  • 10-Yr Bond

    1.2340
    0.0000 (0.00%)
     
  • Vix

    18.80
    +1.22 (+6.94%)
     
  • GBP/USD

    1.3874
    -0.0005 (-0.0347%)
     
  • USD/JPY

    109.9290
    +0.1620 (+0.1476%)
     
  • BTC-USD

    39,402.96
    +2,154.33 (+5.78%)
     
  • CMC Crypto 200

    924.90
    +48.66 (+5.55%)
     
  • FTSE 100

    7,009.13
    +13.05 (+0.19%)
     
  • Nikkei 225

    27,581.66
    -388.56 (-1.39%)
     

OpSens to Participate in Virtual Fireside Chat at the 2021 RBC Capital Markets Global Healthcare Conference

·2 min read

Presentation at 11:30 a.m. ET on Wednesday, May 19, 2021

Logo OpSens Inc. (CNW Group/OPSENS Inc.)
Logo OpSens Inc. (CNW Group/OPSENS Inc.)

QUEBEC CITY, May 13, 2021 /CNW Telbec/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company commercializing a second-generation fiber optic pressure guidewire to diagnose and treat coronary disease, announced today it will participate in a virtual fireside chat at the 2021 RBC Capital Markets Global Healthcare Conference, which is taking place from May 18-20, 2021. Presentation details are listed below.

Presenter: Louis Laflamme, President & Chief Executive Officer of OpSens Inc.

Date: Wednesday, May 19, 2021

Time: 11:30 AM Eastern Daylight Time

Webcast Link: Please click here

The Company will also be participating in one-on-one investor meetings at the conference. To schedule a meeting, please contact your RBC representative or email marie-claude.poitras@opsens.com.

A live webcast of the fireside chat will also be available on the Investors page of OpSens' website at www.OpSens.com and will be archived for two weeks.

About OpSens Inc. (www.OpSens.com or www.OpSensmedical.com)

OpSens focuses mainly on coronary physiology products in interventional cardiology. OpSens offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and excellent lesions access. The OptoWire has been used in the diagnosis and treatment of over 100,000 patients in more than 30 countries. It is approved for sale in the United States, European Union, Japan, and Canada.

OpSens is also involved in industrial activities in developing, manufacturing, and installing innovative fiber optic sensing solutions for critical applications.

SOURCE OPSENS Inc.

Cision
Cision

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2021/13/c7898.html